---
layout: minimal-medicine
title: Tbo-filgrastim
---

# Tbo-filgrastim
### Generic Name
Tbo-filgrastim

### Usage
Tbo-filgrastim is a recombinant human granulocyte colony-stimulating factor (G-CSF) used primarily to reduce the duration of severe neutropenia in adults with non-myeloid malignancies.  This reduction is achieved by administering the drug following myelosuppressive chemotherapy, particularly when there's a significant risk of developing febrile neutropenia (a serious complication characterized by fever and a low white blood cell count).  Essentially, it helps the body produce more neutrophils, a type of white blood cell crucial for fighting infection.


### Dosage
**Adult Dosage (for severe neutropenia prophylaxis in non-myeloid malignancies after myelosuppressive chemotherapy):**  The typical dose is a subcutaneous injection of 5 mcg/kg/day, starting 24 hours after the chemotherapy.  The duration of treatment depends on the individual's neutrophil recovery and is continued until neutrophil counts return to normal.

**Pediatric Dosage:** The safety and efficacy of tbo-filgrastim in children have not been established.  Therefore, it is not recommended for use in pediatric patients.

**Dosage Adjustments:**  The provided information does not detail dosage adjustments for hepatic or renal impairment.  Always consult a healthcare professional for guidance on dosage adjustments based on individual patient factors.

### Side Effects
Common side effects include bone pain.  While less common, more serious side effects can occur.  It's vital to seek immediate medical attention if you experience any unusual or severe side effects.


### How it Works
Tbo-filgrastim works by binding to granulocyte colony-stimulating factor (G-CSF) receptors on the surface of cells responsible for producing neutrophils. This binding stimulates the proliferation, differentiation, and maturation of neutrophils, ultimately increasing their number and activity in the bloodstream. By boosting the neutrophil count, the body becomes better equipped to fight off infections, a crucial benefit for patients undergoing chemotherapy whose immune systems are suppressed.

### Precautions
* **Hypersensitivity:** Tbo-filgrastim should not be used in individuals with a known hypersensitivity to the drug or its components.
* **Caution:** Use caution in patients with a history of splenic rupture, sickle cell crisis, or acute respiratory distress syndrome (ARDS).  Also, use caution when administering tbo-filgrastim with medications that may increase neutrophil release, such as lithium.
* **Pregnancy and Lactation:** Tbo-filgrastim is categorized as pregnancy category C.  The effects on a developing fetus are unknown.  Excretion in breast milk is also unknown.  Therefore, use during pregnancy and lactation requires careful consideration and consultation with a healthcare professional.
* **General Considerations:** Tbo-filgrastim should not be given within 24 hours of chemotherapy administration.  Regular monitoring of complete blood counts (CBCs) is essential before, during, and after treatment to track neutrophil recovery.

### FAQs

* **Q: How is tbo-filgrastim administered?**  A: Tbo-filgrastim is typically administered via subcutaneous injection.
* **Q: How long does it take to see results?** A: The time it takes to see an increase in neutrophil count varies among individuals.  Regular monitoring is crucial.
* **Q: What should I do if I miss a dose?** A: Consult your healthcare provider immediately if you miss a dose. Do not attempt to double up on doses.
* **Q: How should I store tbo-filgrastim?** A: Refer to the medication packaging or your pharmacist for specific storage instructions.
* **Q: Are there any interactions with other medications?** A:  Currently, limited information is available regarding drug interactions.  It is crucial to inform your doctor about all medications you are taking.


**Disclaimer:** This information is intended for educational purposes only and should not be considered medical advice.  Always consult with a qualified healthcare professional before starting or altering any medication regimen.  This information does not encompass all possible uses, side effects, precautions, or interactions.
